Sarepta Therapeutics (SRPT) Interest Coverage Ratio Growth (1y) (2011 - 2022)
Powered by 
Analysis
Sarepta Therapeutics (SRPT) Interest Coverage Ratio Growth (1y) (2011 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -60.78% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -176.09% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 93.04% |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -25.59% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1,170.12% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -53.46% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 99.48% |
| 10 | Sarepta Therapeutics | 2.36 Bn | 1.57 Bn | 251.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -68.52% |
| Sep 30, 2022 | -434.17% |
| Jun 30, 2022 | -20.23% |
| Mar 31, 2022 | 48.14% |
| Dec 31, 2021 | -4.00% |
| Sep 30, 2021 | 82.55% |
| Jun 30, 2021 | -2.62% |
| Mar 31, 2021 | -11.93% |
| Dec 31, 2020 | 66.78% |
| Sep 30, 2020 | 41.84% |
| Jun 30, 2020 | 72.79% |
| Mar 31, 2020 | 16.76% |
| Dec 31, 2019 | -145.50% |
| Sep 30, 2019 | -263.41% |
| Jun 30, 2019 | -287.08% |
| Mar 31, 2019 | -251.95% |
| Dec 31, 2018 | 601.60% |
| Sep 30, 2018 | 104.03% |
| Jun 30, 2018 | 105.76% |
| Mar 31, 2018 | 105.85% |